Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., February 14, 2025, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on December 31, 2024 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results, along with Limited Review Report' for the quarter and nine months ended on December 31, 2024 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 12:30 PM and concluded at 12:50 PM.

pdf

Medico Intercontinental Ltd.

06 Feb 2025

41.24

3.23%

Board Meeting

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Compliance Of Regulation 29, 30 And …

BSE India

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 ,inter alia, to consider and approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter and nine months ended 31st December, 2024 and any other business items as per agenda circulated.

pdf

Medico Intercontinental Ltd.

03 Jan 2025

41.24

3.23%

Company Update

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December, 2024.

pdf

Medico Intercontinental Ltd.

31 Dec 2024

41.24

3.23%

SAST

Medico Intercontinental Ltd - 539938 - Closure of Trading Window

BSE India

Intimation of Closure of Trading Window for Designated persons and immediate relatives of Designated persons.

pdf

Medico Intercontinental Ltd.

15 Nov 2024

41.24

3.23%

Company Update

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication of unaudited financial results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2024.

pdf

Medico Intercontinental Ltd.

14 Nov 2024

41.24

3.23%

Result

Medico Intercontinental Ltd - 539938 - Results - Financials Results For The Quarter And Half Year …

BSE India

Financial Results for the quarter and half year ended 30th September, 2024.

pdf

Medico Intercontinental Ltd.

14 Nov 2024

41.24

3.23%

Board Meeting

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Compliances Of Regulation 30 And 33 …

BSE India

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., November 14, 2024, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2024 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed 'Standalone and Consolidated Unaudited Financial Results, Statement of Assets and Liabilities and Cash Flow Statement along with Limited Review Report' for the quarter and half year ended on September 30, 2024 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com. The Board Meeting of the Company commenced at 12:30 PM and concluded at 01:50 PM.

pdf

Medico Intercontinental Ltd.

06 Nov 2024

41.24

3.23%

Board Meeting

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Board Meeting In Compliance Of Regulation …

BSE India

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve Intimation of Board Meeting for the unaudited financial results for the quarter and half year ended 30th September, 2024.

pdf

Is Medico Intercontinental Ltd. worth buying?

33 Votes:

Buy 75.76%

Sell 12.12%

Hold 12.12%